This project will outline a powerful methodology aimed at delivering important insights into the genetic causes of CP. He predicts that genetic defects collectively constitute a substantial proportion of all CP cases and that recent developments in genomic technology now offer an unprecedented opportunity to acquire a sophisticated understanding of the genetic causes of CP, and ultimately, reduce its impact and prevalence.

Principal Investigator: Dr. John Connolly, Ph.D, Neuropsychologist at the Center for Applied Genomics at the Children’s Hospital of Philadelphia.
connollyjl@chop.edu

BACK